209 related articles for article (PubMed ID: 27349838)
1. Live Streptococcus suis type 5 strain XS045 provides cross-protection against infection by strains of types 2 and 9.
Jiang X; Yang Y; Zhu L; Gu Y; Shen H; Shan Y; Li X; Wu J; Fang W
Vaccine; 2016 Dec; 34(51):6529-6538. PubMed ID: 27349838
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and cross-protective efficacy of double-mutant Streptococcus suis ΔSspepO/ΔSspspC serotypes 2 and 7.
Hu J; Xu J; Liu F; Tan C; Yuan F; Chen H; Bei W
Vaccine; 2019 Apr; 37(16):2194-2199. PubMed ID: 30902483
[TBL] [Abstract][Full Text] [Related]
3. Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection.
Kock C; Beineke A; Seitz M; Ganter M; Waldmann KH; Valentin-Weigand P; Baums CG
Vet Immunol Immunopathol; 2009 Dec; 132(2-4):135-45. PubMed ID: 19505730
[TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant Sao protein confers protection against Streptococcus suis infection.
Li Y; Gottschalk M; Esgleas M; Lacouture S; Dubreuil JD; Willson P; Harel J
Clin Vaccine Immunol; 2007 Aug; 14(8):937-43. PubMed ID: 17567767
[TBL] [Abstract][Full Text] [Related]
5. Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2.
Wisselink HJ; Stockhofe-Zurwieden N; Hilgers LA; Smith HE
Vet Microbiol; 2002 Jan; 84(1-2):155-68. PubMed ID: 11731168
[TBL] [Abstract][Full Text] [Related]
6. Streptococcus suis serotype 9 bacterin immunogenicity and protective efficacy.
Büttner N; Beineke A; de Buhr N; Lilienthal S; Merkel J; Waldmann KH; Valentin-Weigand P; Baums CG
Vet Immunol Immunopathol; 2012 May; 146(3-4):191-200. PubMed ID: 22516423
[TBL] [Abstract][Full Text] [Related]
7. Live attenuated Salmonella enterica serovar Choleraesuis vaccine vector displaying regulated delayed attenuation and regulated delayed antigen synthesis to confer protection against Streptococcus suis in mice.
Ji Z; Shang J; Li Y; Wang S; Shi H
Vaccine; 2015 Sep; 33(38):4858-67. PubMed ID: 26238722
[TBL] [Abstract][Full Text] [Related]
8. Peptidyl isomerase PrsA is surface-associated on Streptococcus suis and offers cross-protection against serotype 9 strain.
Jiang X; Yang Y; Zhou J; Liu H; Liao X; Luo J; Li X; Fang W
FEMS Microbiol Lett; 2019 Jan; 366(2):. PubMed ID: 30629173
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2.
Li J; Xia J; Tan C; Zhou Y; Wang Y; Zheng C; Chen H; Bei W
Vaccine; 2011 Sep; 29(38):6514-9. PubMed ID: 21767591
[TBL] [Abstract][Full Text] [Related]
10. Use of Proteins Identified through a Functional Genomic Screen To Develop a Protein Subunit Vaccine That Provides Significant Protection against Virulent Streptococcus suis in Pigs.
Brockmeier SL; Loving CL; Nicholson TL; Wang J; Peters SE; Weinert L; Chaudhuri R; Seilly DJ; Langford PR; Rycroft A; Wren BW; Maskell DJ; Tucker AW
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203546
[No Abstract] [Full Text] [Related]
11. Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain.
Busque P; Higgins R; Caya F; Quessy S
Can J Vet Res; 1997 Oct; 61(4):275-9. PubMed ID: 9342451
[TBL] [Abstract][Full Text] [Related]
12. Potential use of an unencapsulated and aromatic amino acid-auxotrophic Streptococcus suis mutant as a live attenuated vaccine in swine.
Fittipaldi N; Harel J; D'Amours B; Lacouture S; Kobisch M; Gottschalk M
Vaccine; 2007 May; 25(18):3524-35. PubMed ID: 17296252
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the protective efficacy of four novel identified membrane associated proteins of Streptococcus suis serotype 2.
Zhou Y; Wang Y; Deng L; Zheng C; Yuan F; Chen H; Bei W; Li J
Vaccine; 2015 May; 33(19):2254-2260. PubMed ID: 25820064
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with Streptococcus suis serotype 2 recombinant 6PGD protein provides protection against S. suis infection in swine.
Tan C; Liu M; Liu J; Yuan F; Fu S; Liu Y; Jin M; Bei W; Chen H
FEMS Microbiol Lett; 2009 Jul; 296(1):78-83. PubMed ID: 19459970
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the immune response and evaluation of the protective capacity of rSsnA against Streptococcus suis infection in pigs.
Gómez-Gascón L; Cardoso-Toset F; Tarradas C; Gómez-Laguna J; Maldonado A; Nielsen J; Olaya-Abril A; Rodríguez-Ortega MJ; Luque I
Comp Immunol Microbiol Infect Dis; 2016 Aug; 47():52-9. PubMed ID: 27477507
[TBL] [Abstract][Full Text] [Related]
16. Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization.
Dekker CN; Bouma A; Daemen AJ; van Leengoed LA; Jonker FH; Wagenaar JA; Stegeman JA
Vaccine; 2012 Feb; 30(7):1379-87. PubMed ID: 22210137
[TBL] [Abstract][Full Text] [Related]
17. Evaluation on a Streptococcus suis vaccine using recombinant sao-l protein manufactured by bioreactors as the antigen in pigs.
Hsueh KJ; Lee JW; Hou SM; Chen HS; Chang TC; Chu CY
Transbound Emerg Dis; 2014 Dec; 61(6):e35-43. PubMed ID: 23489297
[TBL] [Abstract][Full Text] [Related]
18. Construction, characterization and evaluation of the protective efficacy of the Streptococcus suis double mutant strain ΔSsPep/ΔSsPspC as a live vaccine candidate in mice.
Hu J; You W; Wang B; Hu X; Tan C; Liu J; Chen H; Bei W
Microbiol Res; 2015 Jan; 170():87-94. PubMed ID: 25220429
[TBL] [Abstract][Full Text] [Related]
19. Salmonella enterica serovar Choleraesuis vector delivering SaoA antigen confers protection against Streptococcus suis serotypes 2 and 7 in mice and pigs.
Li YA; Ji Z; Wang X; Wang S; Shi H
Vet Res; 2017 Dec; 48(1):89. PubMed ID: 29268787
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus suis vaccines: candidate antigens and progress.
Segura M
Expert Rev Vaccines; 2015; 14(12):1587-608. PubMed ID: 26468755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
